
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change.
Peter Muller (Peter.muller@sh-p.com) is Managing Director, Schlafender Hase, Americas (www.text-verification.com)For the last 20 years, Peter Muller has worked on software and process improvement projects with Fortune 500 companies from various industries: Pharmaceutical, Consumer Goods, Food, Aerospace & Defense. He has a wealth of experience working with international clients to define their organization's goals and help them leverage new technologies to achieve productivity gains, process improvements and cost savings.
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change.
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change, writes Peter Muller.
The lines between the pharma and food industries are blurring, presenting a great opportunity for life sciences firms to diversify - as long as they understand the regulatory differences, writes Peter Muller.
Published: August 1st 2016 | Updated:
Published: April 10th 2017 | Updated:
Published: May 1st 2017 | Updated: